M Mańkowski

590 total citations
11 papers, 99 citations indexed

About

M Mańkowski is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Genetics. According to data from OpenAlex, M Mańkowski has authored 11 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 3 papers in Genetics. Recurrent topics in M Mańkowski's work include High Altitude and Hypoxia (3 papers), Respiratory viral infections research (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). M Mańkowski is often cited by papers focused on High Altitude and Hypoxia (3 papers), Respiratory viral infections research (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). M Mańkowski collaborates with scholars based in Poland, United Kingdom and United States. M Mańkowski's co-authors include J Zieliński, M Koziej, Akpay Sarybaev, М М Миррахимов, Christopher E. Brightling, Stephen T. Holgate, Tom Wilkinson, I Hawryłkiewicz, J. Brookes and Victoria Tear and has published in prestigious journals such as Respiratory Research, Open Forum Infectious Diseases and High Altitude Medicine & Biology.

In The Last Decade

M Mańkowski

11 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Mańkowski Poland	4	56	55	33	30	14	11	99
Ramón Coloma Spain	6	29 0.5×	4 0.1×	42 1.3×	60 2.0×	6 0.4×	17	81
Pien F. N. Bosschieter Netherlands	7	59 1.1×	9 0.2×	25 0.8×	78 2.6×	4 0.3×	17	137
P. Roberts United Kingdom	5	23 0.4×	38 0.7×	16 0.5×	7 0.2×	46 3.3×	14	162
Caterina Baldi Italy	7	14 0.3×	53 1.0×	10 0.3×	18 0.6×		11	91
Neli Tsereteli Sweden	5	9 0.2×	18 0.3×	2 0.1×	30 1.0×	15 1.1×	5	100
G Popescu Romania	4	102 1.8×	4 0.1×	64 1.9×	132 4.4×	3 0.2×	12	167
Helene Borrmann United Kingdom	5	82 1.5×	7 0.1×	7 0.2×	44 1.5×	2 0.1×	10	137
Hadassa Rodrigues Santos Brazil	3	5 0.1×	24 0.4×	3 0.1×	13 0.4×	10 0.7×	8	62
Jodie Leditschke Australia	6	41 0.7×	20 0.4×	7 0.2×	2 0.1×	3 0.2×	10	109
Malin Öhlund Sweden	8	11 0.2×	98 1.8×	16 0.5×	30 1.0×	1 0.1×	11	229

Countries citing papers authored by M Mańkowski

Since Specialization

Citations

This map shows the geographic impact of M Mańkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mańkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mańkowski more than expected).

Fields of papers citing papers by M Mańkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mańkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mańkowski. The network helps show where M Mańkowski may publish in the future.

Co-authorship network of co-authors of M Mańkowski

This figure shows the co-authorship network connecting the top 25 collaborators of M Mańkowski. A scholar is included among the top collaborators of M Mańkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mańkowski. M Mańkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Monk, Phillip, J. Brookes, Victoria Tear, et al.. (2024). Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD. Respiratory Research. 25(1). 228–228. 5 indexed citations

Monk, Phillip, J. Brookes, Victoria Tear, et al.. (2022). Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study. ERJ Open Research. 9(2). 605–2022. 11 indexed citations

Monk, Phillip, J. Brookes, Victoria Tear, et al.. (2022). SPRINTER: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Determine the Efficacy and Safety of Inhaled Interferon Beta-1a (SNG001) for the Treatment of Patients Hospitalised Due to COVID-19 (NCT04732949). RCT2884–RCT2884. 1 indexed citations

Monk, Phillip, Rachael A Evans, Victoria Tear, et al.. (2022). LB1533. Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial. Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations

Jończak, Luiza, Paweł Śliwiński, M Mańkowski, et al.. (2008). Dziesięć lat doświadczeń pracowni zaburzeń oddychania w czasie snu w Instytucie Gruźlicy i Chorób Płuc. 69(9-10). 538–544. 1 indexed citations

Jończak, Luiza, P Sliwiński, M Koziej, et al.. (2001). [Ten years experience of the sleep laboratory at the Institute of Tuberculosis and Lung Disease in Warsaw].. PubMed. 69(9-10). 538–44. 3 indexed citations

Zieliński, J, et al.. (2000). The Quality of Sleep and Periodic Breathing in Healthy Subjects at an Altitude of 3200 m. High Altitude Medicine & Biology. 1(4). 331–336. 64 indexed citations

Koziej, M, et al.. (1996). [Obesity and hypoventilation syndrome; effects of weight loss and treatment with respiratory stimulants].. PubMed. 64(9-10). 687–96. 3 indexed citations

Koziej, M, et al.. (1996). [Quality of sleep and periodic breathing during sleep in healthy persons at a height of 3200 meters].. PubMed. 64(9-10). 651–7. 3 indexed citations

10.

Hawryłkiewicz, I, et al.. (1996). [Pulmonary circulation at rest and during exercise in patients with obstructive sleep apnea before and after one year of treatment with CPAP].. PubMed. 64(9-10). 638–43. 4 indexed citations

11.

Mańkowski, M, et al.. (1995). [Clinical picture and outcome of conservative treatment for obstructive sleep apnea].. PubMed. 93(3). 234–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact